Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments, Technology and Professional Services. It offers ignite data and analytics platform that provides clients a single comprehensive environment to integrate and organize data from their disparate software systems; and applications, a software analytics applications build for ignite platform to analyze clients face across clinical improvement, revenue and cost improvement, ambulatory operations, measures and registries, and data and analytics. The company also provides expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. It serves academic medical centers, integrated delivery networks, community hospitals, large physician practices, ACOs, health information exchanges, health insurers, life science organizations, healthcare technology vendors, and other risk-bearing entities. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
Ignite Platform Shift | Health Catalyst's transition to Ignite platform promises higher margins and enhanced flexibility, potentially unlocking significant earnings growth |
Financial Resilience | Despite market challenges, Health Catalyst maintains robust sales pipeline and reaffirms full-year guidance, signaling confidence in growth trajectory |
Strategic Acquisitions | UpFront acquisition strengthens Health Catalyst's position in patient engagement, aligning with industry trends and expanding service offerings |
Analyst Optimism | Price targets range from $9 to $16, with analysts projecting low double-digit revenue growth and 50% adjusted EBITDA growth for fiscal year 2025 |
Metrics to compare | HCAT | Sector Sector - Average of metrics from a broad group of related Technology sector companies | Relationship RelationshipHCATPeersSector | |
---|---|---|---|---|
P/E Ratio | −3.7x | −1.0x | −0.5x | |
PEG Ratio | −0.10 | −0.01 | 0.00 | |
Price/Book | 0.7x | 1.8x | 2.6x | |
Price / LTM Sales | 0.9x | 2.3x | 3.3x | |
Upside (Analyst Target) | 70.2% | 20.9% | 43.5% | |
Fair Value Upside | Unlock | 6.7% | 6.9% | Unlock |